Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice, Associated with an Oxidative Burst and Precocious Profibrogenic Gene Expression by Sebastiani, Giada et al.
Accelerated CCl4-Induced Liver Fibrosis in Hjv-/- Mice,










1Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada, 2Department of Medicine, McGill University, Montreal, Quebec, Canada,
3Department of Diagnostic Sciences and Special Therapies, University of Padova, Padova, Italy, 4Pathology Department, Azienda ULSS 15 Veneto Region, Italy
Abstract
Hereditary hemochromatosis is commonly associated with liver fibrosis. Likewise, hepatic iron overload secondary to
chronic liver diseases aggravates liver injury. To uncover underlying molecular mechanisms, hemochromatotic hemojuvelin
knockout (Hjv-/-) mice and wild type (wt) controls were intoxicated with CCl4. Hjv-/- mice developed earlier (by 2-4 weeks)
and more acute liver damage, reflected in dramatic levels of serum transaminases and ferritin and the development of
severe coagulative necrosis and fibrosis. These responses were associated with an oxidative burst and early upregulation of
mRNAs encoding a1-(I)-collagen, the profibrogenic cytokines TGF-b1, endothelin-1 and PDGF and, notably, the iron-
regulatory hormone hepcidin. Hence, CCl4-induced liver fibrogenesis was exacerbated and progressed precociously in
Hjv2/2 animals. Even though livers of naı ¨ve Hjv2/2 mice were devoid of apparent pathology, they exhibited oxidative
stress and immunoreactivity towards a-SMA antibodies, a marker of hepatic stellate cells activation. Furthermore, they
expressed significantly higher (2–3 fold vs. wt, p,0.05) levels of a1-(I)-collagen, TGF-b1, endothelin-1 and PDGF mRNAs,
indicative of early fibrogenesis. Our data suggest that hepatic iron overload in parenchymal cells promotes oxidative stress
and triggers premature profibrogenic gene expression, contributing to accelerated onset and precipitous progression of
liver fibrogenesis.
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tissues is associated with oxidative stress, cell injury and disease [1].
Hereditary hemochromatosis is characterized by chronic hyper-
absorption and gradual deposition of iron within liver hepatocytes,
while enterocytes and macrophages fail to retain iron due to
inappropriately low expression of hepcidin [2,3,4]. This liver-
derived circulating peptide controls iron fluxes by binding to and
promoting degradation of the iron exporter ferroportin. Hepcidin is
transcriptionally activated in response to iron-dependent and
-independent stimuli by signaling via bone morphogenetic proteins
(BMPs) or proinflammatory cytokines [5,6,7,8]. The most frequent
form of hereditary hemochromatosis is linked to mutations in HFE
[9]. Juvenile hemochromatosis, an early onset variant, is mostly
caused by mutations in hemojuvelin (Hjv) [10], a BMP co-receptor
that is essential for signaling to hepcidin [11].
Development of liver disease is a common complication of
hemochromatosis. Hepatic iron overload predisposes to fibrosis,
cirrhosis and hepatocellular carcinoma [12,13]. Moreover, the
clinical phenotype associated with liver damage may be aggravated
by comorbidities such as chronic viral hepatitis C, alcoholic liver
disease and non-alcoholic steatohepatitis (NASH) [14,15]. Interest-
ingly, these non-hemochromatotic chronic liver diseases are highly
prevalent in the general population and are often associated with
mild to moderate secondary iron overload, which may exacerbate
liver injury and contribute to hepatic fibrogenesis [16,17].
The accumulation of liver fibrosis is a dynamic process
characterized by deposition of collagen and other extracellular
matrix proteins, following activation of quiescent hepatic stellate cells
(HSCs) into a myofibroblast-likephenotype [18,19,20]. This results in
secretion of several pro-fibrogenic cytokines, such as transforming
growth factor beta 1 (TGF-b1), platelet-derived growth factor
(PDGF), endothelin-1 and others. Progression of liver fibrosis towards
end-stage liver disease depends on many cofactors, including hepatic
ironload[12,13,16,17].Nevertheless,eventhoughthetoxicityofiron
is generally attributed to oxidative stress, its exact role in the pathway
of liver fibrogenesis remains unclear.
Rodent models of liver fibrosis recapitulate key aspects of the
pathogenic mechanisms [21,22]. Treatment with carbon tetra-
chloride (CCl4), a known hepatotoxin, represents an established
approach to trigger liver fibrogenesis, which is relatively well
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25138characterized for histological, biochemical and molecular alter-
ations. Iron intoxication, achieved by feeding of animals with
carbonyl iron, was found to act synergistically with CCl4 (or
alcohol) for development of liver damage in most [23,24,25,26]
but not all cases [27,28]. Interestingly, it is believed that unlike in
humans, iron overload per se does not suffice to cause liver fibrosis
in rodents, with the notable exception of gerbils [29,30].
To decipher the role of iron in the development of liver fibrosis,
we employed here Hjv2/2 mice as a genetic model of severe iron
overload. We show that excessive hepatic iron deposition
potentiates chemically-induced liver fibrogenesis by promoting
an oxidative burst and premature induction of profibrogenic
cytokines. Moreover, we demonstrate that naı ¨ve Hjv2/2 animals
manifest early signs of fibrogenesis and liver disease.
Results
Hjv2/2 mice exhibit accelerated liver damage in
response to CCl4 intoxication
Mice with targeted disruption of Hjv spontaneously develop iron
overload due to defective iron sensing and excessive absorption of
dietary iron, constituting an animal model of juvenile hemochro-
matosis [31,32]. To assess the effects of iron overload in liver
fibrogenesis, Hjv2/2 and isogenic wt animals were subjected to
treatment with CCl4 (or corn oil vehicle as control) over a period of
up to 6 weeks. We noticed that mice injected with corn oil were
phenotypically indistinguishable from untreated ones; therefore,
unless otherwise indicated, ‘‘baseline’’ values represent an average
from untreated and corn oil-treated animals.
As expected, untreated Hjv2/2 mice exhibited very high serum
iron indices as compared to wt counterparts (transferrin saturation:
93.864.3 vs 50.867.5%, p,0.0001; serum iron: 57.268.6 vs
36.563.6 mmol/L, p,0.0001; serum ferritin: 10,785.766,120.5 vs
595677 mg/dL, p,0.0001), consistently with an iron overload
phenotype. Serum iron parameters were subsequently analyzed at
different time intervals. Tranferrin saturation remained largely
unaffected by CCl4 in Hjv2/2 mice and appeared to slightly
fluctuate and increase towards the last phase of the treatment in wt
animals (Fig. 1A). Interestingly, CCl4 triggered a sharp ,5-fold
increase in serum iron levels of Hjv2/2 mice that peaked within 2
weeks and decreased afterwards (Fig. 1B). Thiswas accompanied by
a commensurate ,5-fold expansion of total iron binding capacity
(TIBC;Fig.1C),indicatingthat excessofserumironwasshieldedby
transferrin. The CCl4 treatment did not significantly affect serum
iron and TIBC in wt animals.
By the second week of CCl4 treatment, serum ferritin increased
dramatically inHjv2/2 miceto almost60,000 mg/dL, possibly as a
result of inflammation (see also Fig. S3A), and remained extremely
elevated until the sixth week (Fig. 1D). By contrast, in wt mice, very
high ferritinvalues (up to,20,000 mg/dL)wereonlyrecordedatthe
sixth week of CCl4 treatment. Analogous differential responses
between Hjv2/2 and wt mice were observed regarding the CCl4-
dependent induction of serum aspartate aminotransferase (AST) and
alanine aminotransferase (ALT). Thus, Hjv2/2 mice exhibited
remarkably augmented AST and ALT values during the second
week of CCl4 treatment (to ,10,000 and 8,000 IU/L, respectively),
while delayed and comparatively less dramatic responses were
observed in wt animals (Figs. 1E and F). These data suggest that
CCl4 intoxication causes accelerated and more profound liver
damage to Hjv2/2 mice, as compared to wt controls.
Hepatic iron overload potentiates the development of
chemically-induced liver fibrosis
Histological analysis with hematoxylin and eosin (H&E)
revealed advanced coagulative necrosis in liver sections of
Figure 1. Hjv2/2 mice exhibit early and dramatic increases in serum iron indices and transaminases, following CCl4-mediated liver
injury. (A–C) Transferrin saturation, serum iron and TIBC, respectively. (D–F) Levels of serum ferritin and the transaminases AST and ALT, respectively.
The p values refer to Hjv2/2 vs wt and were obtained by the ANOVA test.
doi:10.1371/journal.pone.0025138.g001
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(Fig. 2A and B). Neither Hjv2/2 nor wt livers displayed any
immunoreactivity with caspase-3, a cell death protease and
marker of apoptosis. This seems to be in agreement with the
morphology of cell death in this model of hepatotoxicity, which
mainly shows features of coagulative necrosis. Hepatic damage
developed more gradually in wt animals and reached severe
grades only by the end of the treatment. Within six weeks of
hepatotoxin administration, all Hjv2/2 but half of the wt mice
manifested severe fibrosis (Figs. 2A and C). CCl4-treated animals
of both genotypes progressively developed severe (grade S3)
steatosis (Figs. 2A and D).
The increased susceptibility of CCl4-treated Hjv2/2 mice to
fibrogenesis was validated by visualization of fibrillar collagen
upon van Gieson’s staining (Fig. 3). Thus, livers of Hjv2/2
mice developed rare thin septa at the second week of CCl4
treatment, and numerous septa with architectural alteration and
nodules afterwards. By contrast, in livers of wt mice, rare thin
septa were only visible in the context of necrotic areas during
t h ef o u r t ha n ds i x t hw e e ko fC C l 4 treatment. HSC activation
was assessed by immunohistochemical staining of liver sections
(Fig. S1A) and by Western blotting of liver lysates (Fig. S1B)
with an a-SMA antibody; expression of this marker increased in
response to CCl4 treatment. Semiquantitative analysis of the
amount of positive stained area in the immunohistochemical
experiment shows a time-dependent increase in Hjv2/2 and to
a lesser extent in wt animals. Activated HSCs were mainly
observed at the site of damage, consistently with literature [20].
Nevertheless, densitometric quantification of the Western blot
did not reveal any statistically significant time-dependent
alterations in a-SMA expression among Hjv2/2 and wt mice,
likely attributable to low sensitivity of the assay. A masking
effect due to contribution of further cell types to the generation
of a-SMA expressing activated hepatic myofibroblasts [20] is
also possible.
Staining with Perls’ Prussian blue confirmed the hepatic iron
overload phenotype of Hjv2/2 mice, with iron deposits primarily
detectable in parenchymal cells (Fig. S2A), in agreement with
published data [31,32]. The CCl4 treatment promoted sequestra-
tion of iron in Kupffer cells, a known inflammatory response [33].
In quantitative terms (Fig. S2B), livers from Hjv2/2 mice
contained ,10 times more iron as compared to wt counterparts
(5,769.761,760.1 vs 500.46211.4 mg of Fe per g of dry tissue,
p,0.001). Apparently, hepatic iron loading was not significantly
affected by CCl4.
As expected [31,32], Hjv2/2 mice express pathologically low
levels of hepcidin mRNA (,11 times less than wt, p,0.001;
Fig. 4A), in line with the function of Hjv as a BMP co-receptor that
is necessary for iron-dependent signaling to hepcidin [11].
Interestingly, Hjv2/2 mice manifested a transient dramatic
Figure 2. Hjv2/2 mice develop earlier and more severe liver disease in response to CCl4 intoxication. (A) H&E staining of liver sections
from Hjv2/2 and wt mice subjected to treatment with CCl4 for 1–6 weeks. Controls (ctrl) correspond to livers from untreated Hjv2/2 and wt mice,
which exhibit identical tissue architecture with respective corn oil-treated counterparts. Representative areas with coagulative necrosis (CN), steatosis
(S) and septa (Sep) are indicated by arrowheads. Original magnification 20x. (B–D) Semiquantitative grading of hepatic coagulative necrosis (B)




PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e25138increase in hepcidin mRNA expression during the second week of
CCl4 treatment (compared to Hjv2/2 mice treated with corn oil),
while an analogous response was modest in wt animals (Fig. 4B,
p,0.05). We conclude that hepatic iron overload accelerates and
exacerbates liver damage caused by CCl4.
Hepatic iron and CCl4 synergistically promote early
induction of profibrogenic genes, associated with an
oxidative burst
To unravel the molecular mechanisms by which iron aggravates
CCl4-induced hepatotoxicity, mouse livers were analyzed for
expression of genes that are implicated in fibrogenetic pathways.
The exposure of wt mice to CCl4 resulted in a potent (up to ,125-
fold) activation of a1-(I)-collagen mRNA (as compared to oil-
treated animals), which was evident after the fourth week and
peaked at the sixth week of treatment (Fig. 5A). In Hjv2/2 mice,
CCl4 triggered an earlier induction (,100-fold) of a1-(I)-collagen
mRNA within 2 weeks; notably, a1-(I)-collagen mRNA levels were
almost normalized afterwards.
Similar results were obtained by analyzing the expression of
profibrogenic cytokines (Figs. 5B-D). Hence, in wt mice, the CCl4
treatment caused an induction of the mRNAs encoding TGF-b1
(,6-fold within 2 weeks), endothelin-1 and PDGF (,38- and
,20-fold, respectively, with a peak at 6 weeks). By contrast, in
Hjv2/2 animals, CCl4 elicited accelerated induction of TGF-b1
mRNA within 1 week (,19-fold), as well as endothelin-1 and
PDGF mRNAs within 2 weeks (,32- and ,20-fold, respectively).
Importantly, livers of Hjv2/2 mice manifested an oxidative burst
during the second week of CCl4 treatment, as judged by the ,3-
fold increase in levels of malondialdehyde (MDA), a product of
lipid peroxidation (Fig. 6A). This was also associated with a peak in
TNF-a mRNA expression, which was ,6.7-fold stronger (p,0.05)
in Hjv2/2 animals (Fig. S3A), while IL-1b mRNA levels were
slightly augmented after the second week of CCl4 treatment in all
mice (Fig. S3B). Taken together, these findings highlight a positive
Figure 3. Assessment of fibrillar collagen. Liver sections from CCl4-treated Hjv2/2 and wt mice were stained with van Gieson’s. Septa (Sep) and
nodules (Nod) are indicated by arrows. Original magnification 20x.
doi:10.1371/journal.pone.0025138.g003
Figure 4. CCl4 intoxication promotes profound transient upregulation of hepcidin mRNA in Hjv2/2 mice. (A) Comparison of basal
hepcidin mRNA levels between Hjv2/2 and wt mice. (B) Time-dependent effects of CCl4 treatment on hepcidin mRNA expression. The indicated
induction corresponds to the ratio of hepcidin mRNA values obtained from livers of CCl4- and corn oil-treated animals. The p values refer to Hjv2/2
vs wt and were obtained by the ANOVA test. ** p,0.01 vs wt (Student’s t test).
doi:10.1371/journal.pone.0025138.g004
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fibrogenesis, possibly via an oxidative stress-dependent pathway,
that culminates in precocious activation of profibrogenic gene
expression and upregulation of TNF-a.
Naı ¨ve Hjv2/2 mice exhibit hepatic oxidative stress and
present early signs of liver fibrogenesis
The data in Fig. 6A show a tendency for increased MDA
expression in livers of Hjv2/2 mice as compared to wt controls,
even without CCl4 treatment (week=0). To validate this, we
further analyzed MDA levels in livers of naı ¨ve untreated Hjv2/2
and wt mice. The former exhibited ,50% higher MDA levels
compared to wt (Fig. 6B, p,0.01), indicative of oxidative stress.
Furthermore, Hjv2/2 livers allowed immunohistochemical
detection of 4-hydroxy-2-nonenal (4-HNE), another lipid perox-
idation product (Fig. 6C). As expected, positive 4-HNE staining
was also evident in livers of all CCl4-animals (Fig. S4).
We noticed that livers of oil-treated Hjv2/2 mice expressed
relatively high levels of a-SMA (Fig. S1B, left panel). We further
analyzed the expression of a-SMA in naı ¨ve untreated Hjv2/2
and wt mice by Western blotting and immunohistochemistry.
Only livers of naı ¨ve untreated Hjv2/2 animals had an elevated
a-SMA content (Fig. 7A), associated with the presence of a-SMA-
positive sinusoidal cells (Fig. 7B), demonstrating HSC activation in
the absence of any chemical hepatotoxin.
A comparison of hepatic expression profiles of profibrogenic
genes uncovered higher levels of the mRNAs encoding a1-(I)-
collagen (,3.7-fold, p,0.05), TGF-b1( ,2-fold, p,0.05), endo-
thelin-1 (,4-fold, p,0.05) and PDGF (,5.5-fold, p,0.05) in
naı ¨ve Hjv-/- mice, as compared to wt counterparts (Fig. 8). No
significant differences in the expression of the proinflammatory
cytokines TNF-a and IL-1b were found among the two genotypes
(Figs. S3C and S3D). In conclusion, these data suggest that hepatic
iron overload in Hjv2/2 animals promotes in its own right
oxidative stress, activation of HSCs and profibrogenic gene
expression. Such responses are consistent with early signs of liver
fibrogenesis, prior to the development of fibrosis.
Discussion
We show here that hemochromatotic Hjv2/2 mice are
extremely vulnerable to the hepatotoxicity of CCl4 and develop
premature, and more profound biochemical and histological
symptoms of liver disease compared to wt counterparts. Within
only two weeks of CCl4 treatment, Hjv2/2 mice manifested
dramatic values of serum transaminases and ferritin, as well as
severe hepatic coagulative necrosis (Figs. 1 and 2), which very
likely accounts for the ,5-fold increase in serum iron levels due to
release of the metal from necrotic cells. The parallel elevated
TIBC can be explained by induction of transferrin expression, via
an unknown protective mechanism, which presumably serves to
prevent accumulation of circulating redox-active and potentially
toxic non-transferrin-bound iron (NTBI) [34]. Nevertheless, the
marked increase in hepatic MDA levels (Fig. 6A) strongly suggests
the presence of an at least transient pool of redox-active iron, that
promotes lipid peroxidation. The absence of caspase 3 immuno-
reactivity is consistent with necrotic cell death. Nevertheless, we
cannot exclude that only small amount of caspase-3 (below the
level of detectability) is required or that a caspase-3-independent
form of programmed cell death may be involved.
Contrary to Hjv2/2 mice, wt controls mounted a delayed and
modest increase of serum transaminases and ferritin (but not iron)
after 4 weeks of CCl4 treatment, as a result of gradual
necroinflammatory activity. Importantly, Hjv2/2 mice eventu-
ally developed more advanced fibrosis during the CCl4 treatment
(Figs. 2 and 3). Considering that inflammatory stimuli are known
Figure 5. Precocious expression of profibrogenic molecules in livers of Hjv2/2 mice, following treatment with CCl4. The induction of
the mRNAs encoding a1-(I)-collagen (A), TGF-b1 (B), endothelin-1 (C) and PDGF (D) corresponds to the ratios of respective mRNA values obtained
from CCl4- and corn oil-treated animals. The p values refer to Hjv2/2 vs wt and were obtained by the ANOVA test.
doi:10.1371/journal.pone.0025138.g005
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that the enhanced sensitivity of Hjv2/2 mice to chemically-
induced liver fibrosis is caused by an altered inflammatory
response. Overall, our data strongly suggest that the severe
necrotic damage in livers of Hjv2/2 animals is the consequence
of iron-dependent oxidative stress.
Excessive hepatic iron has been recognized for years as a factor
contributing to the development of liver fibrosis [12,13,16,17].
However, progress in understanding the underlying pathogenic
mechanisms has been hampered by the lack of appropriate animal
models. We employ here for the first time a genetic mouse model
of hemochromatosis to investigate the role of iron in the initiation
of liver fibrogenesis. Previous approaches involved simultaneous
intoxication of rodents with carbonyl iron and a chemical
hepatotoxin (CCl4 or alcohol). While most of the earlier studies
concluded that carbonyl iron enhanced the liver-damaging effects
of chemical hepatotoxins [23,24,25,26], feeding rats with carbonyl
iron failed to potentiate alcohol-mediated liver fibrosis [28] and
has also been reported to protect rats from CCl4-dependent
hepatic fibrogenesis and carcinogenesis [27]. Such discrepancies
may be related to temporal differences in the effects of iron. Our
study is the first one that addresses the role of iron in chemically-
induced liver fibrogenesis in a time-dependent manner. The data
presented here clearly demonstrate that iron elicits early
Figure 7. Evidence for HSC activation in naı ¨ve Hjv2/2 mice. (A) Liver extracts of untreated wt and Hjv2/2 mice (three male and three
female, each) were analyzed by Western blotting with antibodies against a-SMA and housekeeping b-actin. Hjv2/2 mice exhibit marked expression
of hepatic a-SMA (bottom). (B) Immunohistochemical staining with an a-SMA antibody in liver sections of wt and Hjv2/2 mice. Only livers of naı ¨ve
untreated Hjv2/2 mice (right) manifest a-SMA-positive sinusoidal cells (arrows). The small arrows in wt liver section (left) indicate positive internal
control represented by normal portal vessels. Original magnification 20x for wt and 40x for Hjv2/2 liver sections.
doi:10.1371/journal.pone.0025138.g007
Figure 6. Oxidative stress and HSC activation in livers of naı ¨ve Hjv2/2 mice. (A) Evidence for a transient oxidative burst in livers of Hjv2/2
mice, following CCl4 intoxication. Hepatic MDA was quantified by the TBARS assay. The p value refers to Hjv2/2 vs wt and was obtained by the
ANOVA test. (B) Measurement of hepatic MDA levels in naı ¨ve untreated Hjv2/2 and wt mice; data are compiled from n=6 mice in each group. (C)
Immunohistochemical detection of 4-HNE (arrows) in livers from naı ¨ve untreated Hjv2/2 mice; data from one representative Hjv2/2 and wt mouse
are shown. Original magnification 20x. ** p,0.01 vs wt (Student’s t test).
doi:10.1371/journal.pone.0025138.g006
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design is not appropriate. Previous discrepancies may also be
related to variabilities in the distribution of iron deposits among
hepatocytes and reticuloendothelial cells in carbonyl iron intox-
ication models [36], considering that the iron content of
macrophages is crucial for the production of proinflammatory
cytokines via NF-kB [37,38] and for further immune effector
functions [39].
Hjv2/2 mice faithfully reproduce phenotypic hallmarks of
hemochromatosis, such as excessive dietary absorption and
deposition of iron in liver parenchymal cells, while macrophages
remain iron-deficient. Therefore, this model is more pertinent to
address the role of hereditary iron overload in early liver
fibrogenesis. Moreover, elucidating pathophysiological and mo-
lecular responses of Hjv2/2 mice to chemical hepatotoxins may
deserve particular attention in the context of the increased liver
damage documented in hemochromatosis patients when another
cause of hepatic chronic injury is present; for example, chronic
hepatitis C, alcoholic liver disease or NASH [14,15]. The eventual
withholding of iron in macrophages of CCl4-mice is congruous
with the pathology of chronic liver diseases, further indicating the
physiological relevance of the model described here.
The data in Fig. 5 suggest that hepatic iron overload accelerates
the CCl4-mediated induction of profibrogenic molecules such as
a1-(I)-collagen, TGF-b1, endothelin-1 and PDGF, in a synergistic
fashion. A key molecular event with a possible causative role
appears to be the robust precocious activation of TGF-b1 mRNA
expression during the first week of CCl4-treatment. In wt mice this
response is not only delayed (by one week), but also considerably
weaker. In previous experiments, the conditional tetracycline-
inducible overexpression of TGF-b1 sufficed to promote fibrosis in
mice, which was regressed upon switching off transgenic
production of this cytokine [40], suggesting that inhibition of
iron-dependent TGF-b1 activation may mitigate the profibrogenic
effects of iron. Interestingly, the early induction of TGF-b1 mRNA
in CCl4-treated Hjv2/2 mice did not last more than one week.
During the second week of CCl4 treatment, the expression of a1-
(I)-collagen, endothelin-1 and PDGF was likewise transiently
augmented and this correlated with an apparent oxidative burst
(Fig. 6A). The kinetics of a1-(I)-collagen, endothelin-1 and PDGF
mRNA expression exhibit striking similarities with the kinetic
profile of MDA accumulation, suggesting a potential mechanistic
link between profibrogenic gene expression and oxidative stress.
TGF-b1 and a1-(I)-collagen mRNAs were previously reported
to be synergistically upregulated in livers of rats fed with carbonyl
iron and ethanol [25]. Signals for the early potent induction of
TGF-b1 by activated HSCs in Hjv2/2mice may originate from
iron-laden hepatocytes and/or from Kupffer cells. The iron
content of the latter appears to increase substantially during the
CCl4 treatment, consistently with the noticeable upregulation of
hepcidin mRNA (Fig. 4B), which is responsive to inflammatory
stimuli in Hjv2/2 mice [32]. Even though this temporary effect
did not have an impact in overall serum and histological iron
indices, it is likely to modulate cytokine-induced signaling networks
in Kupffer cells [41]. Tissue ferritin is capable of activating IL-1b
expression [42], which in turn is known to stimulate hepcidin
mRNA transcription [43]; nevertheless, the modest induction of
IL-1b mRNA (Fig. S3B) appears to exclude any association
between the dramatic increase in serum ferritin levels (Fig. 1D)
with the hepcidin upregulation (Fig. 4B) in CCl4-treated Hjv2/2
mice.
Another major finding of this work is that naı ¨ve Hjv2/2 mice
express significantly higher basal levels of profibrogenic molecules
(a1-(I)-collagen, TGF-b1, endothelin-1 and PDGF) compared to
wt animals (Fig. 8). Furthermore, livers of naı ¨ve Hjv2/2 mice
contain activated HSCs (Fig. 7) and manifest signs of lipid
Figure 8. Naı ¨ve Hjv2/2 mice exhibit increased expression of hepatic profibrogenic molecules. Comparative expression of the mRNAs
encoding a1-(I)-collagen (A), TGF-b1 (B), endothelin-1 (C) and PDGF (D) in livers from wt and Hjv2/2 mice. *p,0.05 vs wt (Student’s t test).
doi:10.1371/journal.pone.0025138.g008
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the absence of obvious hepatic fibrosis, Hjv2/2 mice initiate
spontaneously fibrogenetic pathways, possibly as a result of iron-
dependent oxidative stress.
It should be noted that iron-loaded livers of hemochromatosis
patients were also found to exhibit oxidative stress and enhanced
expression of TGF-b1 [44], as well as to contain activated HSCs
prior to the development of histological fibrosis [45]. Likewise,
iron-dependent oxidative stress [46] and increase in a1-(I)-collagen
mRNA expression [47,48] has been documented in rats.
Nevertheless, neither intoxication of rats with carbonyl iron
[36,49], nor iron overload of mice with genetically disrupted iron
homeostasis [31,50] appear to cause significant hepatic histological
alterations and liver disease. Among rodents, only gerbils were
reported to develop severe iron-dependent liver damage, following
repeated parenteral injections with iron dextran, which could be
inhibited by the antioxidant vitamin E [29,30]. Along these lines,
due to the absence of significant hepatic fibrosis in Hjv2/2 mice
it has been hypothesized that mice ‘‘may be protected from the
toxic effects of iron overload’’ [31]. However, the data presented
here document a spontaneous early activation of hepatic
fibrogenesis in hemochromatotic Hjv2/2 mice, that may require




All experimental procedures were approved by the Animal Care
Committee of McGill University (protocol 4966). Hjv2/2 mice,
maintained on an inbred 129S6/SvEvTac background [31], were
kindly provided by Dr. Nancy Andrews (Duke University).
Isogenic wild type (wt) mice were purchased from the Charles
River Laboratories (Cambridge, MA). All animals were housed in
macrolone cages (up to 5 mice/cage, 12:12 h light-dark cycle: 7
am–7 pm; 2261uC, 6065% humidity) according to standard
institutional guidelines, and had free access to water and food.
Induction of liver injury by CCl4 intoxication
6-week old Hjv2/2 a n dw tm i c ew e r es u b j e c t e dt ot r e a t m e n t
with CCl4 to induce liver injury, or with sterilized corn oil
vehicle as control. The animals were divided into 4 experimental
groups (n=16 mice for each group): a) Hjv2/2 mice treated
with CCl4;b )H j v 2/2 mice treated with corn oil; c) wt mice
treated with CCl4; and d) wt mice treated with corn oil. CCl4 (2
ml per kg of animal, in a 10% solution of corn oil) or corn oil
were injected intraperitoneally twice per week for up to 6 weeks.
Four mice of each group were sacrificed at weeks 1, 2, 4 and 6 by
cervical dislocation. Age-matched Hjv2/2 and wt mice were
sacrificed without any previous treatment, to obtain baseline
experimental variables. Before sacrifice, the mice were anesthe-
tized and exsanguinated by cardiac puncture to obtain blood
serum.
Serum biochemistry
Transferrin saturation, TIBC and levels of serum iron, ferritin,
AST and ALT were measured by a Roche Hitachi 917 Chemistry
Analyzer at the Biochemistry department of the Jewish General
Hospital.
Preparation of liver samples
Livers were washed with ice-cold phosphate buffered saline
(PBS) and dissected into smaller pieces. Aliquots were snap frozen
at liquid nitrogen and stored at 280uC, or fixed in 10% buffered
formalin and embedded in paraffin.
Quantification of non-heme iron
Hepatic non-heme iron was measured by the ferrozine assay
[51]. Results are expressed as micrograms of iron per gram of dry
tissue weight.
Histological analysis
Deparaffinized liver sections were stained with H&E and with
trichrome stain for collagen. Ferric iron deposits were visualized
by Perls’ Prussian blue with the AccustainH Iron Stain kit (Sigma).
The slides were evaluated by an experienced pathologist who was
unaware of any experimental information. CCl4-mediated coagu-
lative necrosis was graded as mild, when involving only a rim of
perivenular zone 3 hepatocytes and severe when more extensive,
confluent, necrosis was observed involving zone 2 and 1 [52].
Fibrosis was scored as mild (portal-periportal or intralobular
without septa formation) or severe (fibrous septa with or without
cirrhosis) [52]. Steatosis (S) was separately assessed on a four-grade
scale, according to the percentage of hepatocytes with fat [53]
(grade S0, absent; grade S1, ,10% hepatocytes; grade S2, 10–
30%; grade S3, .30%).
Immunohistochemistry
Following deparaffinization, incubation in methanolic H2O
and standard microwave treatment, sections were incubated
overnight at 4uC with mouse monoclonal antibodies against a-
SMA (Biosensis; 1:150 dilution), 4-HNE (Alpha Diagnostic; 1:200
dilution) or caspase 3 (Ab-4 from Calbiochem; 1:40 dilution).
These primary antibodies were previously biotinylated by using
the DAKO
TM ARK (animal research kit). As control, the
primary antibodies were replaced by normal mouse serum. After
wash with PBS, the slides were incubated for 15 minutes with
streptavidin-peroxidase. Staining was completed by incubation
with 3,39-diaminobenzidine (DAB) for 5 minutes, which results in
a brown-colored precipitate at the antigen site. For quantification
of a-SMA, the amount of positive stained area was determined
using an arbitrary semiquantitative score from 0 to 4: 0, no
staining 1, mild-scatter positive staining; 2, moderate staining;
3, marked staining; and 4, intense staining through the liver
parenchyma.
TBARS assay
For the quantification of MDA, frozen liver samples were
disrupted in cold PBS by means of a disposable pestle (Axygen
Inc). The whole homogenate was used for the Thiobarbituric Acid
Reactive Substances Assay (OXItek TBARS Assay Kit, Zeptome-
trix). Results are expressed as nmol of MDA per mg of tissue
weight.
Western blotting
Frozen liver aliquots were suspended in a lysis buffer containing
20 mM Tris-Cl pH 7.4, 40 mM KCl, 1% Triton X-100, an
EDTA-free protease inhibitor cocktail (Roche) and a Halt
phosphatase inhibitor Cocktail (Thermo Scientific), and homog-
enized with a TissueRuptor handheld homogenizer (Qiagen). Cell
debris was cleared by centrifugation and the protein concentration
was measured with the Bradford reagent (BioRad). Protein
extracts (30 mg) were resolved by SDS-PAGE on 10% gels and
the proteins were transferred onto nitrocellulose filters (BioRad).
The blots were saturated with 10% non-fat milk in PBS containing
0.1% (v/v) Tween-20 (PBS-T) and probed with a 1:100 diluted
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with PBS-T, the blots were incubated with 1:5000 diluted
peroxidase-coupled rabbit anti-mouse IgG (Sigma). The peroxi-
dase signal was detected by enhanced chemiluminescence with the
Western Lightning ECL kit (Perkin Elmer).
Quantitative real-time PCR (qPCR)
Total RNA was isolated from frozen liver tissue using the
RNeasy Midi kit (Qiagen); its quality was assessed by determining
the 260/280 nm absorbance ratios and by agarose gel electro-
phoresis. qPCR was performed as previously described [54] by
using gene-specific primers (Table 1). Ribosomal protein S18
(rS18) was used as housekeeping gene for normalization.
Statistical analysis
Quantitative data were expressed as mean 6 standard deviation
(SD). Statistical analysis was performed by using the two-tailed
Student’s t test or the one way ANOVA test, with the GraphPad
Prism software (v. 5.0c). A probability value p,0.05 was
considered to be statistically significant.
Supporting Information
Figure S1 Activation of HSCs in response to CCl4
treatment. (A) Immunohistochemical detection of a-SMA
(arrows) in liver sections from Hjv2/2 (top) and wt (bottom)
mice. Original magnification 20x, except wt mice week 2 (40x). (B)
Western blot analysis of a-SMA and housekeeping b-actin in liver
extracts.
(TIF)
Figure S2 Hjv2/2 mice exhibit severe iron overload in
parenchymal cells, while the CCl4 treatment promotes
iron retention within Kupffer cells. (A) Perl’ s staining of
liver sections from Hjv2/2 and wt mice subjected to treatment
with CCl4 for 1–6 weeks. Iron-loaded Kupffer cells are indicated
with arrowheads. Original magnification 20x. (B) Quantification
of hepatic non-heme iron by the ferrozine assay. *p,0.05 vs wt
(Student’s t test).
(TIF)
Figure S3 Expression of proinflammatory cytokines in
Hjv2/2 and wt mice. (A and B) The induction of TNF-a and
IL-1b mRNAs corresponds to the ratios of respective values
obtained from CCl4- and corn oil-treated animals. The p values
refer to Hjv2/2 vs wt and were obtained by the ANOVA test;
ns=non-significant. (C and D) Comparative expression of TNF-a
and IL-1b mRNAs in livers from naı ¨ve wt and Hjv2/2 mice.
(TIF)
Figure S4 Immunohistochemical detection of 4-HNE
(arrows) in livers of CCl4-treated Hjv-/- and wt mice.
Original magnification 20x, except wt mice week 4 (40x).
(TIF)
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